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Abstract
In Autumn 2011, nonspecific clinical signs of pyrexia, diarrhoea, and drop in milk yield were observed in dairy cattle
near the German town of Schmallenberg at the Dutch/German border. Targeted veterinary diagnostic
investigations for classical endemic and emerging viruses could not identify a causal agent. Blood samples were
collected from animals with clinical signs and subjected to metagenomic analysis; a novel orthobunyavirus was
identified and named Schmallenberg virus (SBV). In late 2011/early 2012, an epidemic of abortions and congenital
malformations in calves, lambs and goat kids, characterised by arthrogryposis and hydranencephaly were reported
in continental Europe. Subsequently, SBV RNA was confirmed in both aborted and congenitally malformed foetuses
and also in Culicoides species biting midges. It soon became evident that SBV was an arthropod-borne teratogenic
virus affecting domestic ruminants. SBV rapidly achieved a pan-European distribution with most countries
confirming SBV infection within a year or two of the initial emergence. The first Irish case of SBV was confirmed in
the south of the country in late 2012 in a bovine foetus.
Since SBV was first identified in 2011, a considerable body of scientific research has been conducted internationally
describing this novel emerging virus. The aim of this systematic review is to provide a comprehensive synopsis of
the most up-to-date scientific literature regarding the origin of SBV and the spread of the Schmallenberg epidemic,
in addition to describing the species affected, clinical signs, pathogenesis, transmission, risk factors, impact,
diagnostics, surveillance methods and control measures. This review also highlights current knowledge gaps in the
scientific literature regarding SBV, most notably the requirement for further research to determine if, and to what
extent, SBV circulation occurred in Europe and internationally during 2017 and 2018. Moreover, recommendations
are also made regarding future arbovirus surveillance in Europe, specifically the establishment of a European-wide
sentinel herd surveillance program, which incorporates bovine serology and Culicoides entomology and virology
studies, at national and international level to monitor for the emergence and re-emergence of arboviruses such as
SBV, bluetongue virus and other novel Culicoides-borne arboviruses.
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Materials and methods
In order to ensure a systematic, up-to-date review of the
literature the following search strategy was implemented.
Harzing’s Publish or Perish software (Windows GUI Edition)
7.10.2373.7118 [1] was used to search and extract relevant
literature from the online databases Google Scholar. The
review keywords “Schmallenberg virus, Culicoides, ruminants
Ireland” (and their combinations using AND/OR) were
entered in the Publish or Perish software. All publications be-
tween the years 2011 (the year Schmallenberg virus was first
identified) and 2019 were searched. No restrictions on
language were imposed so long as an English abstract was
available. All relevant publications were added to the master
list (n = 576). Each publication was then critically evaluated
(removing duplicates) to determine whether it had informa-
tion which met the aim of this review or not; all relevant
publications were then selected for possible inclusion in this
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review. The bibliographies within these publications were
also searched for further relevant publications. In total, 226
publications met the inclusion criteria set out in the aim of
the literature review and so were cited.
Background
Emerging infectious diseases, particularly those caused
by novel emerging pathogens, are causes for concern to
human and animal health globally; approximately 75% of
emerging infectious diseases are zoonotic, originating
principally from wildlife [2]. Similar to the emergence of
bluetongue virus (BTV) in Northern Europe (2006), the
recent and unprecedented emergence of Schmallenberg
virus (SBV) in Germany in 2011 has highlighted the sus-
ceptibility of domestic livestock and wildlife throughout
Europe to arboviruses from distant geographical regions.
During the summer and autumn of 2011, a previously
unknown disease was reported in adult dairy cattle in
Germany and the Netherlands [3]. The disease was char-
acterised by the non-specific clinical signs of pyrexia,
drop in milk yield and sometimes diarrhoea; however,
no known agent could be implicated in the affected cat-
tle. Diagnostic tests excluded a wide range of classical
endemic and emerging viruses, such as pestiviruses, bo-
vine herpes virus type I, foot-and-mouth disease virus,
bluetongue virus, epidemic haemorrhagic disease virus,
Rift Valley fever virus, and bovine ephemeral fever virus,
as the causative agent [3].
Genomic analyses conducted at the Friedrich-Loeffler-
Institut, Germany, on a pool of blood samples collected
from three acutely infected cows identified sequences of a
novel virus in autumn 2011. This new virus was named
Schmallenberg virus (SBV) after the town Schmallenberg
(North Rhine-Westphalia) near which the affected animals
originated [3]. Phylogenetic analysis demonstrated that
SBV is a member of the Simbu serogroup in the Orthobu-
nyavirus genus of the Peribunyaviridae family (order
Bunyavirales). This was the first report to confirm the
emergence of a Simbu serogroup virus in Europe [3].
Other members of this serogroup include Akabane and
Aino viruses (vide infra). In December 2011 and January
2012, an epidemic of congenital malformations was identi-
fied in domestic ruminants in Germany [4, 5] and the
Netherlands [6]. Diagnostic tests on brain tissue samples
collected from malformed lambs and calves confirmed
SBV infection. It soon emerged that SBV is a teratogenic
virus; pregnant female ruminants (cattle, sheep, goats)
which became infected with SBV during the summer and
autumn of 2011 subsequently gave birth to congenitally
infected and malformed offspring. In addition, virus
detection studies confirmed SBV infection in a range of
Culicoides arbovirus vectors, implicating Culicoides spe-
cies in the transmission of the virus [7].
During the spring of 2012, a number of other Euro-
pean countries including France, the United Kingdom
(UK), Luxemburg, Italy and Spain reported confirmed
cases (clinical/pathological signs and PCR- positive) of
SBV infection in malformed calves, lambs and goat
kids. Later in 2012 and in 2013, cases of congenital
Schmallenberg disease were confirmed in a number of
countries across Europe [8–10] (Fig. 1).
The first Irish case was confirmed in late October
2012 in a bovine foetus at the Cork Regional Veterinary
Laboratory [11]. Subsequently, congenitally malformed
calves and lambs displaying lesions consistent with SBV
were confirmed by PCR in the latter months of 2012
and up to May 2013 [11]. These cases were in the south
and south east of the country [11]. A national Irish ser-
osurvey conducted in late 2012 demonstrated that
much of the south and south east of the country had
been exposed during 2011 and 2012, while the north
and north west remained predominantly unexposed
[12]. A bulk-tank milk (BTM) surveillance study found
no evidence of further spread of SBV in dairy herds in
the south west of Ireland during 2013 [13]. This is in
contrast with other European countries such as
Germany [14] and Belgium [15], where SBV appeared
to re-emerge in cattle herds and sheep flocks during
2012-2013, albeit at a considerably lower level com-
pared to 2011-2012. In the four years (2012 to 2015)
following the initial European Schmallenberg epidemic
there were a number of reports of SBV overwintering
and continued virus circulation at low levels in several
European countries [16–19].
However, there was little or no evidence of SBV cir-
culation in Ireland in the three years (2013-2015) fol-
lowing the initial emergence of SBV in Ireland in 2012
[20]; a similar situation was present in the UK [21] and
in the Netherlands [22]. In Ireland it is possible that a
high herd immunity (animal-level seroprevalence was
62.5 % in spring 2014) may have reduced the SBV’s
ability to circulate in animals in previously exposed
herds in the vector seasons of 2014 and 2015 [20]. SBV
is typically highly efficient in spreading in herds in the
presence of transmitting vector species [23, 24]. This is
due to the rapid rate of virus replication and the high
probability of transmission from host to vector [25].
This is supported by evidence of high within-herd sero-
prevalence in cattle and sheep after the 2011/2012
Schmallenberg epidemic [26]. These epidemiological
characteristics of SBV result in a high basic reproduct-
ive number (R0), estimated to be as high as 6.2 for
cattle-only farms and 7.6 for sheep-only farms [25],
which reduces the probability of finding low numbers
of seropositive animals once the virus has circulated in
a naïve ruminant population [20]. Using this R0 value,
it is interesting to note that the effective reproductive
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number (Re = R0 × fraction of the population of suscep-
tible animals) in animals in previously exposed herds in
Ireland in spring 2014 (one year after the Irish Schmal-
lenberg epidemic) would have been greater than one
(Re = 2.33; Re = 6.2 × 0.375) highlighting the potential
for SBV to re-circulate in these herds during 2014 and
subsequent vector seasons, despite a perceived high
herd immunity [20].
In 2016, SBV re-emerged and recirculated in Ireland,
the UK and in Belgium [27–29] resulting in a second
outbreak of abortions and congenital malformations in
ruminants. SBV was also confirmed in regions that
had previously been unaffected by SBV (north and
north west of Ireland [30]), and in countries outside of
the EU [31–38], highlighting the continued geograph-
ical expansion of SBV. The virus continued to circu-
late in Ireland and the UK in 2017, which is in
contrast with other European countries which have
not (yet, September 2019) reported notable SBV circu-
lation during this time (Fig. 2) [39]. Further research
is recommended to determine the extent of SBV circu-
lation in continental Europe during this time.
The pathogen
Virus structure and genome
Similar to other members of the Peribunyaviridae fam-
ily, SBV is an enveloped virus with a genome composed
of three negative-sense single-stranded RNA segments
which are named according to their size: Small (S),
Medium (M) and Large (L) [40]. It is assumed that
these segments have a similar coding capacity and pro-
teins to other related Orthobunyaviruses [41]. Consid-
ering that SBV is an arbovirus, antigenic drift in the
virus genome is considered limited because the virus
relies on vector transmission; mutations which could be
advantageous for replication in the final host might be
disadvantageous in the vector [42]. This bottleneck has
also been seen with other RNA viruses that are trans-
mitted by mosquito vectors, such as Venezuelan equine
encephalitis virus [43]. This is supported by reports of
high SBV genetic stability in vector-derived SBV se-
quences in Poland [44]. Additionally, Hoffmann et al.
(2015) reported that SBV has a relatively low mutation
rate both in vitro and in vivo [45]. Several field studies
of virus variability have also demonstrated that the
Fig. 1 Schmallenberg disease distribution by country and date of initial report of detection by serology and/or RT-qPCR. Map created with
mapchart.net ©
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virus is relatively stable over time [46, 47]. Some varia-
tions in the SBV genome have been reported in the
time since the virus first emerged in Europe in 2011
[48–50]. Of the three SBV RNA segments, the M-
segment, which encodes two surface glycoproteins
(glycoprotein n; Gn and glycoprotein c; Gc) and one
non-structural protein (NSm), is considered the most
variable segment within the SBV genome. Similar to
Akabane virus [51], the M segment of SBV possesses a
hypervariable region within the sequence coding for
glycoprotein Gc, lending it to be the most variable seg-
ment within the genome [48, 49, 52]. The SBV L-
segment encodes RNA-dependent RNA polymerase
[53, 54] while the S-segment encodes the nucleoprotein
N and the non-structural protein NSs [49].
Virus classification and origin
Schmallenberg virus (SBV) is a Simbu serogroup virus in the
genus Orthobunyavirus (Family Peribunyaviridae, order
Bunyavirales) [53]. There are over 170 viruses within the
Orthobunyavirus genus including viruses responsible for dis-
ease in humans (Oropouche virus, La Crosse virus) and in
ruminants (Akabane virus, Aino virus, Cache Valley Fever
virus). The Simbu serogroup viruses are prevalent in Africa,
Oceania, and the Middle East and include more than 25
viruses such as Oropouche, Simbu, Akabane, Douglas,
Sathuperi, Aino, Shamonda and Peaton viruses [53]. Aka-
bane virus (AKAV) [55, 56], Aino virus (AIV) [57, 58] and
Shamonda virus (SHAV) [59, 60] can cause similar clinical
signs and pathology to Schmallenberg virus (vide infra) [26].
When SBV was first discovered in 2011, metagenomic
analyses revealed that the virus shared similar genomic
sequences with three other Orthobunyaviruses which
also infect cattle; Shamonda (SHAV), Aino (AIV) and
Akabane (AKAV) viruses [3]. None of these viruses
have been detected in Europe to date (September
2019). Interestingly, SBV sequences share a 69% iden-
tity with the Akabane virus L-RNA-segment, 71% iden-
tity with the Aino virus M-RNA-segment and 97%
identity with the Shamonda virus S-RNA-segment [3].
Phylogenetic analyses of SBV have revealed that it may
be a reassortant virus with the M RNA-segment from
Sathuperi virus and the S and L RNA-segments from
Shamonda virus [60]. However, one study based on
phylogenetic and serologic analyses, produced conflict-
ing results with Yanase et al. (2012) [60]; Goller et al.
(2012) suggested that SBV belongs to the Sathuperi
virus species and may be an ancestor of Shamonda
virus [61]. Understanding the exact phylogeniology of
SBV has proven challenging, particularly considering
the fact that a number of the Simbu viruses have yet to
be fully sequenced. Further research in this area is rec-
ommended; understanding the phylogeniology of SBV
may help elucidate the origin and the epidemiological
circumstances surrounding the emergence of this novel
virus in Europe.
Currently (September 2019), the geographical origin of
SBV also remains unknown. The distribution of closely re-
lated Simbu serogroup Orthobunyaviruses (Aino, Akabane,
Sathuperi and Shamonda viruses) in Africa and Australasia
[59] suggest that SBV may have been introduced into Europe
from distant geographical regions. Some reports suggest that
aircraft transporting animals from an area where SBV may
be enzootic or in virus-infected midges may be involved in
the introduction of SBV into Europe [62]. It is interesting to
note that SBV emerged in a similar geographical location
(triangular region located at the border of Germany, Belgium
and The Netherlands) to where bluetongue virus serotype 8
(BTV-8) emerged 5 years previously [63]. One could hy-
pothesise that both SBV and BTV-8 were introduced into
Fig. 2 Schmallenberg virus timeline between 2011 and 2019
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Europe via a similar, but not yet defined, route [64, 65]. A
model demonstrated that the majority of SBV infections in
the UK in 2012 occurred as a result of SBV-infected midges
being transported through downwind movement facilitated
by prevailing winds from continental Europe [66], most likely
from Northern France [67]. Similarly, the emergence of SBV
in Ireland in 2012 has been attributed to the transport of
SBV-infected Culicoides in wind movements from Southern
England [68]. Interestingly, when SBV sequences collected
during the SBV re-emergence in the UK in 2016-2017 were
compared with those originally isolated in the UK in 2012, a
second distinct clade of SBV was identified; further research
is required to determine if these novel viruses represent a re-
incursion from continental Europe or were derived through
spatial separation of viruses already present in the UK [67].
Host range
Ruminant species
Schmallenberg virus primarily infects ruminants. Direct
and indirect detection of SBV in has been identified in cat-
tle, sheep and goats (either in adult animals or in their off-
spring) [4–6, 69]. SBV RNA or antibodies have been
detected in a wide range of wild and exotic ruminants
(alpacas, elk, State Anatolian and Congo water buffalo,
European bison, red deer, fallow deer, roe deer, sika deer,
llama, reindeer, moufflon, water buffalo and chamois) and
camelids in a number of European countries including
France, Germany, the Netherlands, Sweden and the UK
[26, 70, 71], and in wild (fallow, red and sika) deer in
Ireland [72]. In Spain, SBV antibodies were also confirmed
in wild (red, fallow) deer and also wild moufflon [73].
Experimental infection with SBV in alpacas and llamas re-
sulted in sub-clinical infection with detectable SBV-RNA
viraemia for 3 to 7 days post inoculation [74]. In Poland, a
cross-sectional study of Schmallenberg virus seropreva-
lence in wild ruminants at the end of the vector season of
2013 suggested that wild ruminants might play a role in
SBV transmission, however the lower seroprevalence in
relation to the domestic ruminants suggests the spill-over
effect from the latter, rather than inverse [75]. SBV anti-
gen was also confirmed in the serum of a 6-month-old elk
found in Białowieża national park in Poland, however no
clinical sign were observed [76]. This may be due to the
free-ranging nature of these wild animals and the limited
contact with humans. In Belgium, Italy and France, SBV
antibodies were also confirmed in wild ruminants (wild
cervids and wild alpine ungulates) [77–80]. Additionally,
serum samples collected from a wide range of zoo rumi-
nants have also tested positive for SBV antibodies in the
UK [26, 81], in France and in the Netherlands [82]. In
contrast to domestic ruminants, clinical signs associated
with SBV infection have not been described in these wild
and exotic species; further investigation is required to
clarify the effects of SBV infection in these species and to
assess their role in the epidemiology of SBV [75, 76].
Non-ruminant species
Owing to the fact that a number of viruses in the
Orthobunyavirus genus can cause disease in humans,
one of the most critical questions regarding SBV dur-
ing the initial epidemics was whether SBV transmis-
sion from animals to humans was possible. Molecular
and serological investigations in highly exposed hu-
man populations in Germany and in the Netherlands
revealed no evidence of SBV infection; neither SBV-
RNA nor antibodies were detected [83, 84]. Evidence
of indirect SBV infection has been reported in a range
of non-ruminant species. SBV-specific antibodies have
been detected in free-ranging wild boar in a number
of countries including Germany [85], Belgium [86],
Poland [87] and Spain [73]. A limited number of re-
ports suggest that SBV infection can occur in dogs. In
France SBV-RNA was detected in the brain of a puppy
with torticollis and degenerative encephalopathy,
while SBV antibodies were detected in its mother [88].
SBV antibodies were also reported in one dog without
clinical signs in Sweden [89]. However, SBV sero-
logical investigations in 132 dogs in Belgium [90] and
in wild carnivores in Germany [85] found no evidence
of SBV infection. Experimental SBV infection in pigs
leads to transient seroconversion, however no SBV-
RNA was detected [91] suggesting they may become
infected but do not develop disease. SBV antibodies
have also been detected in exotic zoo species (onager,
Grevy’s zebra, Asian elephant and babirusa) in two
zoological parks in the UK [26, 81]. Previously, The
European Food Safety Authority considered that
horses did not play a role as a reservoir in the epi-
demiology of SBV [26]. However, one recent study re-
ported the detection of SBV-specific antibodies in
horses in Iran; this is the first reported evidence of
SBV infection in equine species [35]. However, the re-
sults of this study should be interpreted with caution;
these positive results were not confirmed using virus
neutralisation tests and SBV RNA was not detected
[35]. Moreover, the animals tested originated in the
Simbu serogroup endemic areas of northern and
northeast Iran; the possibility of cross-reaction with
other related Simbu serogroup viruses such as Shuni
(SHUV), Aino (AINV), and Akabane (AKAV) virus
could not be excluded [35].
Clinical signs and lesions
In female dairy cattle (pregnant and non-pregnant), SBV
infection can cause short-duration, non-specific and
somewhat inconspicuous clinical signs such as pyrexia
(fever up to 41°C), drop in milk yield and diarrhoea [3].
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Clinical signs in adult cattle typically last for up to 6
days and are closely associated with the short-duration
SBV viraemia [3, 92]. In small ruminants SBV infection
is typically subclinical, however clinical signs such as
fever, decreased milk production and diarrhoea are
reported to occur during the viraemic phase [93].
Congenital foetal Schmallenberg virus infection in naïve
ewes and goats can result in abortions and stillbirths
with or without congenital malformations [93]. In goats,
one study reported a reduction in milk yield of up to
50% in the lactating flock [94]. In sheep flocks anecdotal
evidence suggests that lactating sheep also experienced
fever, diarrhoea and decreased milk production, however
a conclusive link to SBV infection could not be deter-
mined [95]. In sheep experimentally infected sheep with
SBV, one RNAemic sheep showed diarrhoea for several
days, but fever was not recorded in any of the animals
[92]. Experimental infection with SBV in adult female
(non-pregnant) goats and bucks resulted in seroconver-
sion, but inoculated goats did not display any clinical
signs, gross lesions or histological lesions, nor was SBV
RNA detected semen samples collected from two virus
inoculated bucks [96].
The most notable clinical signs associated with SBV infec-
tion are those observed in the offspring of animals that be-
come infected during the critical stage of gestation resulting
in congenital Schmallenberg disease. As described for AKAV
and AIV, in-utero infection with SBV can cause abortions,
premature or stillbirths, mummified foetuses and congeni-
tally malformed offspring characterised by the Arthrogrypo-
sis-Hydranencephaly-Syndrome (AHS) (Figs. 3 and 4).
Subsequent to the emergence of SBV in Germany in 2011,
SBV was implicated in an epidemic of congenitally mal-
formed lambs in the Netherlands; SBV antigen was detected
in approximately 50% of brain tissue samples collected from
affected lambs [6]. This was the first report to demonstrate
the ability of SBV to cross the placenta in and induce terato-
genic effects in developing embryos/foetuses [6].
SBV infection during early gestation in cattle has also
been associated with embryonic mortality and return to
oestrus [97–99]. This is supported by reports of reduced
fertility in SBV-affected herds in Switzerland (increased
number of inseminations per cow) [100], in Germany and
in the Netherlands in 2011 (repeat oestrus, increased num-
ber of abortions and short gestations and an increase in the
number of artificial inseminations per cow) [99]. In rumi-
nants, the primary pregnancy recognition signal is an inter-
feron (IFN-tau); interestingly a number of studies have
shown that the NSs protein of SBV plays a major role in
inhibiting IFN production and contributes to SBV patho-
genesis [101–103]. Reports of abortions and increased
numbers of repeated oestruses suggestive of early embry-
onic mortality have also been attributed to SBV infection in
sheep flocks [95, 97, 104, 105] and goat flocks [94, 97]. In
Ireland when SBV re-emerged during 2017, one dairy
farmer reported severely reduced fertility; it was estimated
that 25% of herd, which had previously been confirmed
pregnant, had aborted [106].
In pluriparous animals, the birth of one congenitally
infected offspring and one non-infected offspring has
been reported in SBV-infected calves [69] and lambs [6].
Congenitally infected SBV neonates can also survive
birth; congenitally infected lambs have been reported to
present with a range of clinical signs such as malforma-
tions, “dummy lambs” unable to suckle, weak lamb syn-
drome, non-specific neurological signs and normal
presentation [6, 107]. One report of a calf born at full
term describes a range of neurological signs also; hyper-
tonicity, hyperreflexis, depression, blindness, ventrolat-
eral strabismus and inability to stand [108]. These
neurological signs, in addition to reports of musculoskel-
etal malformations, indicate that SBV has a tropism for
the central nervous system (CNS) and musculoskeletal
system in developing embryos. Target cells of SBV infec-
tion include neurons in the cerebral cortex, brainstem
and spinal cord [102, 109]. Varela et al. (2013) report
that malformations and deformities observed in SBV-
infected lambs and calves are accompanied by muscle
hypoplasia and demyelination; SBV appeared to infect
the neurons of the grey matter of the spinal cord, sug-
gesting that muscular hypoplasia and muscular defects
observed in SBV infected lambs and calves are mostly
secondary to damage of the central nervous system
(CNS) [102].
Unlike AKAV, where there are a small number of re-
ports of a highly virulent AKAV strain known as the
Iriki strain which can cause encephalomyelitis in natur-
ally infected adult cows [110], there are no reports to
date of SBV-associated lesions in naturally infected non-
pregnant adult cattle other than pyrexia, diarrhoea and
Fig. 3 Bovine foetus congenitally infected with Schmallenberg virus
presenting with severe arthrogryposis of all four limbs, torticollis,
kyphosis, brachygnathia inferior, and skeletal muscle hypoplasia.
Image courtesy of Dr. John Mee, Teagasc, Ireland
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milk drop. However, a range of pathological findings are
reported in congenitally infected foetuses and neonates
with presumptive or confirmed SBV infection (Table 1).
The severity of congenital Schmallenberg virus CNS
lesions may be greater in lambs than in calves [109], this
may be due to the shorter length of gestation in sheep
(approximately 5 months) compared to cattle
(approximately 9 months).
Fig. 4 Ovine foetuses congenitally infected with Schmallenberg virus; image (a) & (b) from the same lamb presenting with severe arthrogryposis
of all four limbs, torticollis, brachygnathia infectior and skeletal muscle hypoplasia. Image (c) of a second lamb presenting with scoliosis and
bending and twisting of the forelimbs. Images courtesy of Cosme Sanchez Miguel, DAFM, Ireland
Table 1 Reported pathological findings associated with natural congenital Schmallenberg virus infection in domestic ruminants
(bovine, ovine and caprine)
Species Gross pathology Histopathology References
Bovine Head and CNS Non-suppurative meningo-encephalitis, [108, 109, 111, 112]
Porencephaly, hydranencephaly, brain stem hypoplasia,
cerebellar hypoplasia, cerebellar dysplasia, micromyelia
Non-suppurative poliomyelitis, skeletal
muscle hypoplasia, lymphoid depletion
in thymus and lymph node, chronic hepatitis
Skeletal
Arthrogryposis, torticollis, lordosis, scoliosis, kyphosis,
cranial malformations, brachygnathism inferior, prognathia
Visceral
Ectopia cordis, pulmonary hypoplasia, ventricular
septal defect
Ovine Head and CNS Non-suppurative meningo-encephalitis,
skeletal muscle hypoplasia, lymphoid
depletion in spleen or lymph node, cataract,
haematopoietic cellularity in bone marrow
[4, 6, 109]
Brachynathism inferior, domed skull, flattened skull,
hydranencephaly, hydrocephalus, micrenencephaly,
macrocephaly, brainstem hypoplasia, cerebral hypoplasia,
cerebellar hypoplasia, cerebellar dysplasia, micromyelia
Skeletal
Arthrogryposis, torticollis, lordosis, scoliosis, kyphosis,
Visceral
Cardiac ventricular septal defect, unilateral hydronephrosis,
colonic atresia
Caprine Head and CNS Non-suppurative meningo-encephalitis,
nonsuppurative poliomyelitis
[4, 113]
Hydrocephalus, porencephaly, cerebellar hypoplasia
Skeletal
Arthrogryposis, vertebral deformities, brachynathism inferior
Visceral
Pulmonary hypoplasia,
This table is adapted from Doceul et al. (2017) [114]
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The CNS, the axial skeleton and skeletal muscle are
the most commonly reported sites for congenital mal-
formations, individually or in combination, in domes-
tic ruminants [4, 6, 109, 111]. Arthrogryposis can be
pathognomonic for SBV infection and can be associ-
ated with skeletal muscle hypoplasia, with histological
evidence of decreased number and diameter of
myofibrils, with and without loss of cross-striation in
myofibrils and fatty replacement [4, 111]. In the CNS,
the most commonly reported lesions described are
hydranencephaly, porencephaly, hydrocephalus, cere-
bellar hypoplasia and micromyelia (Table 1), with
histological evidence of non-suppurative inflamma-
tion, neuronal degeneration and necrosis (Table 1).
Malformations of the vertebral column can also be
pathognomonic for SBV infection and include lordo-
sis, kyphosis, scoliosis, kypho-scoliosis and torticollis
(Table 1), a number of animals are also reported to
have brachygnathia inferior [109].
Pathogenesis
As SBV is a relatively newly discovered virus, the patho-
genesis of Schmallenberg disease is poorly defined. This
is further complicated by the fact that only a limited
number of studies have been reported investigating the
pathogenesis of SBV in domestic animals (Table 1).
When an adult animal is bitten by an infectious Culi-
coides vector, they can become infected with SBV and de-
velop viraemia (Fig. 5), [3, 115]. SBV infection induces
long-duration protective immunity in cattle [116, 117] and
sheep [118]. However, if a naïve adult animal develops SBV
viraemia during the critical stage of gestation (Fig. 5), the
virus can cross the placenta and infect the foetus, possibly
resulting in congenital Schmallenberg disease. While the
gestation-susceptible period for AKAV has been defined in
domestic ruminants (see Section Vertical Transmission vide
infra), it has yet to be determined for SBV; it is assumed to
be similar to that of AKAV [26]. However, a number of
studies which have tried to elucidate the most susceptible
stages of gestation for congenital SBV disease (based on the
critical period for AKAV), have only led to foetal malforma-
tions in a very limited number of cases (Table 1).
The susceptibility of developing embryos/foetuses to
SBV infection may depend on the maturity of the pla-
centomes. Experimental infection with SBV in pregnant
ewes at 45 days and 60 days of gestation resulted in pla-
cental colonization [119]; interestingly, in this study sig-
nificantly more positive samples, from both extra-
embryonic structures and lamb organs, were found in
new-born lambs originating from ewes that were in-
fected at day 60 compared to those infected at day 45
suggesting that that placentomes at 45 days of gestation
are not sufficiently developed to sustain intensive viral
replication, in contrast, placentomes at 60 days of gesta-
tion were [119]. Experimental infection with SBV in
pregnant goats demonstrated vertical SBV infection dur-
ing early pregnancy spanning at least the period between
day 28 and 42 of gestation; this resulted in foetal mortal-
ities, viable foetuses displaying lesions of the central ner-
vous system, as well as viable foetuses without any
detectable lesion [120]. There is no documented evi-
dence of pathology in the developing embryo after
Fig. 5 Arbovirus vector-mediated transmission cycle. (1) Extrinsic incubation period (EIP); the time during which an infected insect becomes
infectious. (2) Vector-to-host transmission of virus through the bite of an infected Culicoides. (3) Intrinsic incubation period (IIP), the time during
which the host becomes infectious. (4) Host-to-vector transmission of virus; when uninfected female Culicoides bite infected infectious hosts and
become infected
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AKAV infection in pregnant females during early ges-
tation (first three weeks in small ruminants and the
first two months in cattle), suggesting that the em-
bryo may be protected from viral infection [56, 121].
The stage of development of the foetus and foetal im-
mune system may also influence the outcome of
foetal SBV infection. For example, studies have sug-
gested that ovine foetuses may be more susceptible to
SBV infection before the blood-brain barrier is devel-
oped (in sheep the blood-brain barrier starts to de-
velop between days 50 and 60 of gestation and
reaches full development by day 123) [102]. In
AKAV-infected lambs, transplacental infection as early
as 64 days of gestation can induce an immune re-
sponse and the production AKAV-protective anti-
bodies [122]. Similarly, pre-colostral SBV-specific
antibodies can be detected in neonatal calves where
the dam was (presumably) infected with SBV between
day 47 and 162 of gestation [69].
The use of laboratory-based small animal models,
principally mouse models, has facilitated research stud-
ies on the biology and pathogenesis of SBV. In vitro
and in vivo studies have demonstrated that the SBV
non-structural protein NSs is an important virulence
factor [102] and has an important role in SBV patho-
genesis [103, 123]. A mouse model has been developed
in NIH Swiss mice to study SBV infection in brain tis-
sue; intracerebral SBV inoculation resulted in deaths
and severe brain lesions (malacia and haemorrhage of
the cerebral cortex, multifocal vacuolation in the white
matter of the cerebrum, and lymphocytic perivascular
cuffing in the grey matter) [102]. Embryonated Chicken
Egg models (ECEs) have been used previously to study
the pathogenesis of a number of Simbu viruses [124–
128]. More recently, Collins et al. (2018) demonstrated
that ECE models are also suitable in vivo small animal
models to study SBV infection [129]. Barry et al. (2014)
demonstrated an association between activated caspase-
3 (indicator of apoptosis) and SBV in the brain tissue of
NIH Swiss mice inoculated intracerebrally [103]. Type I
interferon receptor knock-out (IFNAR-/-) mice are also
susceptible to SBV infection and can develop fatal dis-
ease and are thus a useful model to study SBV [130].
The effects of AKAV infection on developing em-
bryos vary depending on the stage of gestation at
which the dam becomes infected [131]. While, it is
assumed this is similar for congenital SBV infection,
further research is required to help elucidate the age-
associated effects of SBV infection on developing em-
bryos. The gestation-susceptible period for congenital
AKAV infection is between day 28 and 56 days in
small ruminants [55, 121, 122, 132], and between day
80 and 150 in cattle [56, 133–135]. However, experi-
mental SBV infection in domestic ruminants during
these dates has led to congenital malformations only
in a very small number of cases (Table 2). This high-
lights the need for further research in this area; the
development of suitable ruminant models to study
SBV infection in developing embryos would be useful
to help elucidate SBV pathogenesis.
Transmission
Arthropod vectors
SBV is an arthropod-borne virus transmitted by haema-
tophagous arthropods from the Culicoides genus (Diptera:
Ceratopogonidae). The arbovirus transmission cycle be-
tween vector and host is illustrated in Fig. 5. Uninfected
Culicoides take a blood meal from a SBV-infectious host
(ex: bovine, ovine, caprine). Culicoides become infectious
(SBV replicates to transmissible levels within the midge)
during the extrinsic incubation period (EIP), which is as-
sumed to range between 9 and 41 days depending on
microclimatic temperatures on farms [136]. Virus trans-
mission from vector to host occurs when infectious female
Culicoides bite immunologically naïve animals and trans-
mit the virus via their saliva. The intrinsic incubation
period for SBV can range from 2-6 days [3].
In order to implicate potential Culicoides species in
SBV transmission, Culicoides specimens (entire speci-
mens or heads only) can be tested for SBV RNA using
RT-qPCR. Regarding entire specimen analysis, pigmen-
ted (parous; Culicoides that have oviposited and blood-
fed at least once) Culicoides specimens are considered
more appropriate for virus detection studies compared
to nulliparous, blood-fed or gravid Culicoides specimens
for a number of reasons. Pigmented (parous) Culicoides
are likely to survive long enough for virus replication
and dissemination within the vector and complete a full
lifecycle (Fig. 5) resulting in full dissemination of the
virus within the insect. In contrast, nulliparous Culi-
coides are not considered appropriate because they have
not yet taken a blood meal from a mammalian host.
However, it must be noted that nulliparous Culicoides
can test positive for SBV RNA; this is suggestive of
transovarial transmission within the vector [137, 138].
Blood-fed Culicoides are also considered inappropriate
because positive detection of virus RNA could be a re-
sult from the blood meal in their mid-gut rather than
fully disseminated virus infection in the midge (i.e. the
virus may be present in the mid-gut but not present in
the Culicoides salivary glands). While gravid Culicoides
could be used in theory (as there is no longer a blood
meal in the abdomen), positive detection of virus RNA
could be ambiguous as it could be a result of residual
virus present in their mid-gut from a previous blood
meal, rather than a result of fully disseminated virus in-
fection in the midge. An alternative method to analysing
entire Culicoides specimens is to remove the head of the
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insect and analyse them separate to the body. While this
method may be somewhat laborious, it would remove a
certain degree of ambiguity regarding positive results in
the case of entire Culicoides specimen analysis.
Virus detection studies in field-caught Culicoides popula-
tions have implicated a range of Palearartic Culicoides in
the transmission of SBV; SBV RNA has been detected in
members of the Culicoides Obsoletus group (C. obsoletus,
C. scoticus, C. dewulfi and C. chiopterus) and in members
of the Culicoides Pulicaris group (C. pulicaris and C. punc-
tatus), (Fig. 6) [7, 139–144]. SBV-RNA has also been
detected in field-caught C. nubeculosis, C. imicola, C.
newsteadi, C. lupicaris [144] (Note that C. lupicaris is cur-
rently considered a synonym of C. delta (preferred) by the
UK reference laboratory), suggesting that these species may
be involved in SBV transmission; however conclusive evi-
dence of the potential role of these species in SBV trans-
mission is required. Vector competence (the intrinsic ability
of an arthropod to become infected, to support the devel-
opment or replication of a pathogen, and to transmit it to a
vertebrate host) has been demonstrated for both C. obsole-
tus and C. scoticus in laboratory experiments [145–147].
More recently, Pagès et al. (2018) demonstrated that Culi-
coides in the Obsoletus group and C. imicola are highly
Table 2 Overview of experimental and field studies with Schmallenberg virus in domestic ruminants contributing to our
understanding of the efficacy of transplacental crossing, the capacity to induce congenital malformations, and the relationship
between clinical and pathological malformations observed at birth in offspring and the moment of gestation at which the dam
became infected
Study
type
Virus
strain
Species No.
studied
Inoculation
route
Stage of
gestation (day)
at infection
Stage progeny
examined
Major Outcome Reference
Exp. Field
+ FLI
inoculuma
Cattle 24 Sub-cutaneous 60-150 6 weeks PI Preliminary data; indications for
efficient placental crossing but
limited capacity to induce
malformations
Schmallenberg
virus: Final Report
EU, 2014c
+ FLI
inoculuma
Cattle 11 Sub-cutaneous 105-120 10-28 DPI Preliminary data; indications
for efficient placental crossing
but limited capacity to induce
malformations
Schmallenberg
virus: Final Report
EU, 2014c
+ Field Cattle 71 Vector-
mediated
13-162 At birth Evidence of transplacental SBV
infection only found in 13% of
calves at birth; only 1 calf with
malformations
[69]
+ Field Cattle 36 Sub-cutaneous 60-150 10-35 DPI SBV genome was detectable
in at least one organ system
of 18 out of 35 foetuses, but
limited capacity to induce
malformations
[225]
+ FLI
inoculuma
Sheep 21 Sub-cutaneous 38-45 7 DPI Preliminary data; indications
of transplacental crossing
in 64% of foetuses at 7 DPI;
no malformations observed
Schmallenberg
virus: Final Report
EU, 2014c
+ FLI
inoculuma
Sheep 28 Sub-cutaneous 45-60 At birth Evidence of transplacental
SBV infection only found in
14% of lambs at birth; no
congenital malformations observed
[119]
+ FLI
inoculuma
Sheep 17 Sub-cutaneous 45-60 At birth Evidence of transplacental
SBV infection; no congenital
malformations observed;
Placenta of 5 ewes contained
infectious SBV at birth
[168]
+ FLI
inoculuma
Goats 10 Sub-cutaneous 28-42 14-25 DPI Preliminary data; several
haemorrhagic and small
foetuses observed after
SBV infection
Schmallenberg
virus: Final Report
EU, 2014c
+ Field C/S/G 13 Vector-
mediated
32-81 NS 13 cows with early foetal death
after SBV infection
[98]
Table adapted from De Regge et al. (2017) [226]. Exp Experiment, NS Not specified, C Cattle, S Sheep, G Goats, DPI Days post inoculation
aInoculum consisting of bovine serum collected 3 days post SBV infection, prepared and distributed by Friedrich Loeffler Institute
bSchmallenberg virus, March 2014, Technical and scientific studies, Final Report for the European Union Commission implementing Decision of 27 June 2012:
available online at library.wur.nl/WebQuery/wurpubs/fulltext/310772
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susceptibility to SBV infection in laboratory studies
highlighting their role as competent SBV vectors [148].
Field data have confirmed the vector competence of C.
obsoletus, C. scoticus, C. dewulfi and C. chiopterus [7, 149].
The role of mosquitos in SBV transmission has also been
investigated and results indicate that they are not compe-
tent vectors; no evidence of SBV RNA was detected in 50,
000 mosquitos trapped in Germany in 2011 [150], nor was
there evidence for the persistence of Schmallenberg virus in
overwintering mosquitoes in the Netherlands [151]. Experi-
mental oral infection of two mosquito arbovirus vector spe-
cies (Aedes albopictus and Culex pipiens) did not result in
SBV replication to transmissible levels, indicating that these
two species are not SBV arbovirus vectors [146]. In
Germany, black flies (Diptera: Simuliidae) were also ana-
lysed for the presence of SBV and proved negative [152].
One study investigating Culicoides species in nine Euro-
pean countries demonstrated that the Culicoides Obsoletus
ensemble (in this study the “Culicoides Obsoletus ensem-
ble” refers to the Culicoides Obsoletus group and C. dewulfi
together and includes the following species: C. obsoletus, C.
scoticus, Culicoides montanus Shakirzjanova, Culicoides
chiopterus (Meigen) and C. dewulfi) is widely distributed in
Europe accounting for 83% of all specimens (8,842,998
specimens) identified [153]. In Ireland, Collins et al. (2018)
demonstrated an abundance of putative Culicoides arbo-
virus vector species on Irish cattle farms, demonstrating the
potential for future transmission of arboviruses among live-
stock on farms [154]. A Department of Agriculture, Food
and the Marine (DAFM) Culicoides survey conducted in
Ireland between 2007 and 2009 as part of the National
BTV vector surveillance programme also indicated the
presence of several Culicoides arbovirus vector species in
Ireland [155].
A number of countries across Europe have established
national surveillance systems to monitor Culicoides spe-
cies and abundance to monitor for the (re-)emergence
and (re-)circulation of arboviruses such as BTV. How-
ever, arbovirus surveillance programs which solely moni-
tor vectors (Culicoides species) for evidence of infection
are not considered the most effective programs to detect
arbovirus circulation or emergence [20]. Virus detection
(sensitivity) in insect specimens is frequently lower when
compared to mammalian samples [20, 26]. Moreover,
the detection of SBV in midges can be ambiguous as it
does not always mean the virus is present at transmis-
sible levels; bimodal distributions of cycle threshold (Ct)
values for SBV in Culicoides sp. is reported suggesting
that the virus can be present in the vector at transmis-
sible and sub-transmissible levels [137, 149].
Vertical Transmission
In ruminants, if a pregnant female becomes infected
with SBV (through a bite from infected Culicoides) she
can develop a viraemia which may result in vertical
transmission of SBV across the placenta into the foe-
tus(es). Foetal infection with SBV during the critical
stage of pregnancy can result in congenital Schmallen-
berg disease; the gestation-susceptible period for con-
genital Schmallenberg disease is not yet defined, it is
assumed to be similar to that of Akabane virus; be-
tween day 28 and 56 days in small ruminants [55, 121,
122, 132] and between day 80 and 150 in cattle [56,
133]. Vertical transmission in cattle, sheep and goats
has been demonstrated by the detection of SBV RNA in
congenitally malformed neonates, stillborn and aborted
foetuses [4, 6, 108, 112]. While SBV infection has been
Fig. 6 Wing patterns of Culicoides arbovirus vector species present in Ireland and the UK; (1) C. obsoletus/C. scoticus, (2) C. chiopterus, (3) C. dewulfi,
(4) C. pulicaris, (5) C. punctatus. Images courtesy of The Pirbright Institute
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detected in non-ruminant species, vertical transmission
has not been reported.
Horizontal transmission
Experimental subcutaneous inoculation of cows with
SBV resulted in detectable concentrations of SBV RNA
in faecal, oral and nasal swabs [92]. In contrast, experi-
mental oral inoculation of cattle and nasal inoculation of
sheep did not result in SBV RNA viraemia and animals
remained seronegative [92, 115, 156, 157]. These find-
ings suggest that direct transmission of SBV from one
infected ruminant to another by direct contact, by oral
route or by nasal route is unlikely. The possibility of
venereal SBV transmission has not yet been fully deter-
mined; SBV has been detected in bovine semen samples
collected from bulls naturally infected with SBV [158–
162] however, it remains unknown whether females can
become infected via this route. Experimentally infected
goat bucks did not show evidence of SBV shedding in
semen [96]. Interestingly, viraemia was produced in cows
inoculated with Akabane virus into the uterus at oestrus
[163], suggesting AKAV infected semen resulted in vir-
aemia. Further research studies in this area using SBV
are recommended.
Overwintering
SBV appears to have the ability to overwinter, that is, to
survive for prolonged periods in vectors and/or in hosts
during lower vector activity when no new hosts appear
to become infected [26]. The mechanism by which this
occurs is not fully understood. One of the first reports of
SBV overwintering occurred during the winter of 2011-
2012 in France; in May 2012, eight months following the
most likely introduction date of SBV into France [164],
evidence of acute infection was detected in cows sug-
gesting SBV overwintered or was re-introduced during
the winter of 2011-2012 [165]. Furthermore, in the three
years (2012, 2013 and 2014) following the European
Schmallenberg epidemic there were additional reports of
SBV overwintering and continued virus circulation in
several European countries [16, 17, 19, 140, 166].
A number of hypotheses have been proposed in order
to help elucidate SBV overwintering. Overwintering in
animal hosts has been explored though not yet proven,
however this is unlikely due to the short-duration vir-
aemia associated with SBV infection [3], and the low
SBV RNA detection rates in malformed lambs and calves
[167]. A recent study demonstrated that SBV can persist
until birth in the placenta (cotyledons and intercotyle-
donary membranes) of ewes infected with SBV-
infectious serum at day 45 and 60 of gestation [168].
This persistence of SBV for at least 100 days in pregnant
ewes is a new aspect of SBV pathogenesis and could help
to explain how SBV overwinters the cold season in
temperate climate zones [168]. There is no documented
evidence of persistently infected foetuses in pregnant
hosts as seen with Bovine Viral Diarrhoea virus (BVDv)
persistently infected animals.
Limited data suggest that SBV may overwinter in Culi-
coides vectors, possibly via transovarial transmission; two
studies report the detection of SBV RNA in nulliparous
Culicoides (C. obsoletus/C. scoticus, C. pulicaris and C.
punctatus) [137, 138] and also in a pooled sample of
male C. scoticus specimens [138]. These findings suggest
the potential for transovarial transmission of SBV in
arbovirus vectors; this may play an important epidemio-
logical role in SBV overwintering. Overwintering in adult
midges during the winter has also been considered.
Adult midges of the Culicoides Obsoletus group are able
to survive for long periods (for up to 10 days at 4°C and
up to 92 days at temperatures ranging between 17°C and
35°C) without a blood meal [169]. These findings suggest
that infected midges could persist during cooler months
of the year and infect hosts once temperatures rise to
temperatures that are more favourable for virus trans-
mission. This is supported by evidence of SBV transmis-
sion in Germany in the winter of 2013 following a brief
rise in temperature above 5°C for a couple days [23].
Risk factors
The risk of SBV infection in domestic ruminants appears
to differ among farm animal species, for example: within-
group seroprevalence was typically lower in sheep flocks
compared to cattle herds in Germany [69, 170, 171] and
SBV seroprevalence was lower in goats compared to sheep
in Belgium [172]. One study demonstrated that goats have
a lower risk of SBV infection compared to sheep [171].
These findings suggest that the risk of SBV infection may
be due to the inherent differences in the susceptibility of
domestic ruminants to SBV infection. An alternative ex-
planation may be due to Culicoides host species prefer-
ences. Cattle are the preferred host for the most common
Culicoides arbovirus vector species [173, 174]. The differ-
ences in the exposure of host species to Culicoides arbo-
virus vectors, for example, different housing conditions
and farming practices should also be considered. Dairy
cattle herds managed outside appeared to have higher
SBV seroprevalence compared to herds kept indoors, most
likely due to the lower midge activity indoors [99, 175].
Similar results were also found in goats where flocks man-
aged outdoors had high within-herd SBV seroprevalence
[94, 176].
Timing of the reproductive season, particularly in sheep
flocks with early breeding seasons (which overlapped with
the Culicoides vector-active season), was also identified as
a risk factor for congenital Schmallenberg disease [95]. As
SBV infection induces long-duration immunity in cattle
[116, 117] and sheep [118] (assumed life-long based on
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other Simbu Orthobunyaviruses), the age of the animal is
also considered a risk factor for SBV infection; animals
born after the initial Schmallenberg epidemic (after 2013)
and animals which were not exposed to SBV in the years
following the initial epidemic (2013-2019), are considered
most at risk of infection [20, 22].
Impact
The primary clinical impacts of SBV infection in domestic
ruminants (cattle, sheep and goats) are embryonic mortality,
abortions and congenital malformations of foetuses which
become infected with the virus in utero [26, 97, 177, 178].
The impact of SBV infection on adult animals is primarily
due to dystocia in cattle and sheep as a result of malformed
calves and lambs [178] and from a drop in milk production
in dairy cattle [99, 100, 179].
Sheep flocks are likely to be more susceptible to the
impact of SBV infection than cattle herds due to the
compact nature of the sheep breeding season [9]. These
species-specific patterns are often influenced by the time
interval in pregnancy during which transplacental infec-
tion can lead to foetal damage [180]. For example, early
lambing sheep flocks are at greater risk of congenital
Schmallenberg disease [181]; this is because the gesta-
tion susceptible period of early lambing ewes can overlap
with the Culicoides vector-active season, enabling con-
genital SBV infection. This is consistent with reports of
substantial losses associated with mortality and congeni-
tal malformations in early lambing sheep flocks [9, 95,
182]. In the Netherlands, deformities in lambs varied
from mild to severe, and ewes were reported to have
given birth to normal lambs, deformed lambs and
dummy lambs that were unable to suckle; dystocia was
also common [6]. In the UK, a sheep farmer survey that
was conducted following the initial SBV epidemic re-
ported that lamb and ewe losses were high on farms
where SBV was confirmed or suspected [183]. In the
same survey, the median number of lambs born (and the
median number of deformed lambs) that died within
one week of birth per 100 ewes were 18.2 (5.5) on farms
where SBV was confirmed,11.3 (2.9) where SBV was sus-
pected and 8.6 (0.0) where SBV was not suspected, re-
spectively, while 8 to 16 per cent of SBV confirmed or
suspected farms reported lamb mortality of ≥40 per cent
[183]. Stokes et al. (2018) conducted a similar survey in
the UK to determine the farm-level impact of SBV dur-
ing the 2016–2017 lambing season and describe compar-
able results to the findings reported for the 2011/2012
outbreak; higher neonatal lamb mortality, dystocia and
associated ewe deaths, and higher perceived impacts on
sheep welfare, flock financial performance and farmer
emotional wellness were reported on SBV confirmed (n=
59) and SBV suspected (n=82), than SBV not suspected
(n=74) farms [184].
In France the SBV impact in infected ruminant herds
was primarily due to the birth of stillborns or deformed
foetuses and neonates while the median frequency of
morbidity was significantly higher in SBV-infected lambs
compared to calves and kids; on average 8% of lambs,
3% of calves and 2% of kids were born with typical SBV
malformations [97]. In the same French study, farmers
reported retrospectively a lower prolificacy during the
vector season, suggesting a potential impact of acute
SBV infection during mating and early stages of gesta-
tion [97]. In Irish sheep flocks, the weaning rate in con-
firmed SBV-infected sheep flocks was found to be
approximately 10% lower than in uninfected flocks
[185]. Similarly, the results of a survey investigating the
impact of SBV infection in sheep flocks in Belgium re-
vealed a two-fold reduction in expected flock prolificacy
in 2012 [105]. Preliminary studies on SBV infection in
sheep flocks in France in 2012 reported mortality rates
of up to 15%, albeit with considerable between-flock
variation [186]. Congenitally malformed calves and
lambs that survive are typically unsuitable for breeding
or for sale, which has had an economic impact on
farmers. The emotional impact of SBV infections has
been also been reported; many sheep farmers with flocks
affected by SBV reported distress due to the sight of
congenitally malformed lambs and also stress associated
with the emergence of a novel disease in their flocks
[183]. While the overall economic impact of the SBV
epidemic in Europe appears to be limited, the conse-
quences have been substantial in farms with a high
prevalence of clinical disease [106].
The most significant impact of Schmallenberg virus
has been international trade restrictions, particularly
in live animals and semen; a number of third coun-
tries (Non-EU) restricted cattle semen trade which re-
sulted in an estimated drop of 11-26 % in the
number of semen doses exported by Europe in 2012
[26]. Moreover, the official statistics (EUROSTAT) on
semen exports from pure-bred breeding animals show
that the export value dropped from almost 590 mil-
lion Euros in 2011 (heifers, cows and other breeding
animals) to 475 million Euros in 2012 (a decline of
20 per cent) [26].
The financial impact of SBV infection on individual
livestock farms varies widely. One study in Belgium
attempted to quantify the financial cost of SBV infec-
tions; the mean cost for individual symptomatic treat-
ment of SBV-infected animals was estimated to be 65
and 107 Euros in the case of fatal outcome or apparent
recovery, respectively [107]. Economic models have also
been developed to estimate the financial costs of SBV in-
fection on livestock farms in the UK and France; Häsler
et al. (2015) developed a model to estimate the cost of
SBV infection per cow space per year for an average
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dairy farm with 100 milking spaces in both high and low
impact scenarios in the UK and in France [187]. The re-
sults showed that the net SBV disease costs in the UK in
£/cow space/year was estimated to be £16.3 and £51.4 in
the high impact scenario and between £8.2 and £25.9 in
the low impact scenario, respectively [187]. In France,
the net SBV disease costs in £/cow space/year ranged
from £19.6 to £48.6 in the high impact scenario and £9.7
and £22.8 in the low impact scenario, respectively [187].
A similar model was developed for sheep flocks in the
UK and in France [188]; the estimated net SBV disease
cost per year and ewe was £19.65-£20.85 for the high
impact scenario and £6.40-6.58 for the low impact sce-
nario. No major differences were observed between the
different production types [188]. For France, the net
SBV disease cost per year and ewe for the meat and milk
sheep holdings ranged from £15.59-£29.81 for the high
impact scenario and £4.75-£10.34 for the low impact
scenario depending on production type [188].
Diagnostics
Virus detection
In congenitally malformed calves and lambs the pre-
ferred sample materials for detecting SBV RNA via RT-
qPCR are brain stem, placenta, and meconium [167,
189]. Pre-colostral serum and foetal fluids can also be
used to detect SBV-specific neutralising antibodies inde-
pendently, or as an adjunct to tissue samples [167, 190].
For semen samples, frozen diluted or undiluted bull
semen samples can be tested using RT-qPCR to detect
SBV RNA [158–162]. Real-time reverse transcription
quantitative polymerase chain reaction (RT-qPCR) is the
method predominantly used for the direct detection of
SBV antigen; due to the characteristics of the analysis
such as high sensitivity, relatively time-efficient assay to
perform and the possibility for high throughput screen-
ing. Different PCR systems have been developed to tar-
get either the S, M or L segment of the virus [3, 189,
191]; the S segment-based assay is considered the most
suitable in terms of sensitivity and specificity for the de-
tection of SBV RNA. A pan-Simbu RT-qPCR assay for
the detection of a number of Simbu serogroup viruses
has also been developed [191]. RT-qPCR assays are also
used for the detection of SBV antigen in insect vectors
[20, 137, 144–146, 192].
Virus isolation in various cell lines has also been used;
SBV can be isolated on insect cell lines such as KC
(Culicoides variipennis cell line), or mammalian cell lines
such as Vero (African Green Monkey) or BHK (Baby
Hamster Kidney) cells [3, 115].
Antibody detection
The detection of SBV-specific antibodies may be a
more reliable diagnostic test in adult animals
compared to virus detection considering the short
duration of viraemia (approximately 4-6 days) and the
non-specific clinical signs associated with SBV infec-
tion in adult animals [3, 92, 115, 117]. Moreover, the
detection of SBV-specific antibodies in foetal heart
blood (aborted foetuses) or in serum collected prior to
ingestion of colostrum (neonates) can confirm con-
genital SBV infection [69, 167, 190]. Serum is the
matrix of choice for detecting SBV RNA and anti-
bodies in adult animals [26]. Milk (lacto-serum) sam-
ples can also be used to detect SBV-specific antibodies
[193]. Similar to a number of other livestock diseases
such as Bovine Viral Diarrhoea and Bovine Leukemia
[194, 195], a number of research studies have investi-
gated the relationship between SBV antibody titres in
serum and milk samples. Bulk tank milk antibody
titres are highly predictive of within-herd SBV sero-
prevalence and can be used as a surveillance tool to
monitor SBV infection dynamics in dairy cattle herds
[196]. One study demonstrated that antibody titres in
individual animal milk samples were significantly
higher when compared to serum samples in dairy cat-
tle [197]. A number of countries in Europe have used
BTM-ELISA results to monitor SBV infection dynam-
ics in dairy herds [13, 198, 199]. Virus-specific anti-
bodies can be detected in serum and milk using a
variety of assays including in-house and commercial
ELISAs (there are several commercial antibody ELISA-
Kits available), micro-neutralisation and indirect im-
munofluorescence tests [193, 200–202]. A European-
wide ring trial demonstrated limited inter-laboratory
variation in the detection of SBV-specific antibodies in
serum and that the virus neutralisation test was more
sensitive compared to a number of different ELISAs
[203]. While the SBV virus neutralisation test is highly
specific [61, 204], the S-segment based ELISAs could
lead to cross-reactivity between SBV and other Simbu
viruses [114]. This is particularly important to con-
sider in the context of selecting the most appropriate
diagnostic tests to use in order to confirm the emer-
gence of SBV in new geographical regions. Currently
(September 2019), SBV is the only known Simbu ser-
ogroup Orthobunyavirus virus reported in Europe.
Surveillance
A number of surveillance systems were established across
Europe in order to monitor for SBV (re-)emergence and
(re-)circulation. These included syndromic surveillance,
sentinel herd surveillance, cross-sectional seroprevalence
studies and pathogen surveillance in animals and vectors.
In the Netherlands a syndromic surveillance system based
on routinely collected cattle reproduction and milk pro-
duction data proved effective for the early detection of
outbreaks of Bluetongue and Schmallenberg viruses [205].
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Regional sentinel veterinarians were also used in a France
to monitor suspect SBV cases (arthrogryposis-hydranen-
cephaly syndrome) in ruminants [206]. A Culicoides
dispersion model has been developed by DAFM in con-
junction with the Irish Meteorological Office (Met Éir-
eann) and UCD Centre for Veterinary Epidemiology and
Risk Analysis to monitor weather conditions which may
favour a possible incursion of Culicoides from the UK and
continental Europe [68]. However, it is recognised that
microclimatic temperatures provide better estimates of
vector-borne disease transmission parameters when com-
pared to standard meteorological temperatures, as the
microclimate represents the actual temperatures to which
the vectors are exposed [136]. Vector-borne disease trans-
mission models for Schmallenbreg virus commonly use
mathematical equations originally developed for Blue-
tongue virus serotype 9, for example Bessel et al. (2014)
[136, 181] and Haider et al. (2018). This is often because
there are no specific experimental data on the relationship
between temperature and virus replication rate (extrinsic
incubation period) in Culicoides midges for SBV. Further
research in this area is recommended in order to deter-
mine the microclimatic conditions which are favourable
for SBV replication in Culicoides species; this could enable
more reliable predictions of SBV epidemics.
Within the first 2.5 years of the emergence of the first
SBV cases in Germany in 2011, the virus had achieved an
almost pan-European distribution (Fig. 1). To date (Sep-
tember 2019), the virus has been confirmed in almost all
European countries including Austria [98], Belgium [108],
Croatia [207], Denmark [143], France [165], Germany [3],
Great Britain (England, Scotland and Wales) [27, 208],
Greece [209], Hungary [50], Ireland [11], Italy [210],
Luxembourg, Latvia, Estonia, Finland and the Czech Re-
public [211], The Netherlands [6], Northern Ireland [212],
Norway [213], Portugal [214], Romania [215], Serbia [216],
Slovenia [217], Spain [218], Sweden [89, 199], Switzerland
[19] and Turkey [10]. It is likely that the neighbouring
countries have also had SBV infections but confirmed cases
have not yet been reported. A model for the transmission
of SBV between regions in Europe suggested that vector
dispersal is the principal mechanism for transmission of
SBV, even at the continental scale [219]. More recently,
SBV has been reported in countries outside of Europe, in-
cluding Azerbaijan [31], China [32], Ethiopia [33, 34], Iran
[35], Lebanon [36], Namibia [38] and Mozambique [31, 37]
suggesting possible geographical expansion of SBV. How-
ever, reports of SBV emergence in new geographical re-
gions which are based solely on serological detection of
SBV antibodies, particularly when samples originate in re-
gions where other Simbu viruses are known to be enzootic,
should be interpreted cautiously as some ELISAs can have
cross-reactivity between SBV and other Simbu viruses
[114].
Schmallenberg virus re-emergence and recirculation
occurred in cattle herds in Ireland [106] and in the UK
[27, 184, 220] during 2016 and 2017 resulting in a drop
in milk yield and congenital malformations in calves and
lambs. More recently (January/February 2018), SBV in-
fection was also confirmed in malformed bovine foetuses
in Ireland [106]. While a number of these cases are in
livestock in regions where SBV had circulated previously,
confirmed reports of SBV emergence in the north and
north west of Ireland (where the virus had not been de-
tected previously), suggests geographical expansion of
SBV into regions with little, if any, SBV herd or flock
immunity [30]. Reports of SBV re-emergence and recir-
culation during 2017 is restricted to Ireland and the UK;
this may be due to lack of notable virus circulation (pos-
sibly due to high herd immunity/endemic circulation) in
continental Europe or possibly underreporting/cases not
yet reported. Further research is recommended to deter-
mine the current herd immunity to SBV in Europe; this
information can in turn be used by policy makers, veteri-
narians and farmers to inform decisions regarding the
future risk of SBV circulation and possible epidemics.
A sentinel surveillance program to monitor SBV infec-
tion in Irish cattle herds proved very effective in moni-
toring for SBV recirculation and re-emergence [20, 28].
This type of surveillance model is not unique, in fact a
number of countries have established similar arbovirus
monitoring/surveillance programs, typically at a national
level. For example, in Australia, the National Arbovirus
Monitoring Program (NAMP) is very effective in moni-
toring arboviruses such as Akabane, bluetongue and bo-
vine ephemeral fever viruses [221]. The NAMP model
monitors sentinel farms throughout the country (in en-
demic areas, border regions and disease/vector-free
areas) on a permanent basis using serology, virus isola-
tion and vector surveillance (Culicoides species) [221].
Future arbovirus surveillance work in Ireland and in
Europe could be based on such a program; the establish-
ment of a European-wide sentinel herd surveillance pro-
gram, which incorporates bovine serology and Culicoides
entomology and virology studies to monitor for the
emergence and re-emergence of arboviruses such as
SBV, bluetongue virus and other novel Culicoides-borne
arboviruses is recommended.
Control and prophylaxis
In response to the European Schmallenberg epidemic in
2011-2012, a number of research studies aimed to develop
suitable SBV vaccines for use in domestic ruminants to
protect against SBV infection. Wernike et al. (2013) devel-
oped four vaccine prototypes which completely prevented
viraemia in cows after challenge infection [222] while
Hechinger et al. (2014) developed and inactivated SBV
vaccine requiring only a single immunization in sheep
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resulting in complete inhibition of viral replication in im-
munized animals [223]. A double deletion mutant of
Schmallenberg virus (modified live vaccine) was also re-
ported avirulent and protected animals against SBV infec-
tion [224]. Subsequently three inactivated commercial
vaccines (Zoetis Zulvac [Zoetis Belgium SA, Rue Laid
Burniat 1, 1348 Louvain-la-Neuve, Belgium], Bovilis® SBV
[Intervet UK Ltd. Milton Keynes, Buchinghamshire,
United Kingdom] and SBVvax [Merial SAS, Lyon,
France]) were developed for use in cattle and sheep. These
vaccines were marketed in France and the UK in 2013, in
the Republic of Ireland in 2014, and later marketed to the
rest of the Europe in May 2015. In Scotland, one study
which developed a stochastic mathematical model of SBV
spread to investigate the optimal deployment of a vaccine
found that SBV vaccine impact is optimised by targeting it
at high risk areas or vaccinating only cattle [181]. The
same study also demonstrated that at higher than average
temperatures, and hence increased Culicoides transmis-
sion potential, the relative impact of vaccination was also
considerably enhanced [181]. Despite the initial uptake of
vaccine among veterinarians and farmers in Ireland, both
vaccines were subsequently withdrawn from the Irish
market due to a reduction in demand. Currently (Septem-
ber 2019) there is no SBV vaccine licenced for use in
Ireland. There is no specific treatment available for SBV
infection.
Alternative, but less reliable control measures have
been proposed. As SBV is an insect-transmitted virus,
the use of insecticides or repellents directed against
vectors could, in theory, be useful to prevent virus
transmission from virus-infected midges to susceptible
animals. However, one case-control study demonstrated
no evidence of protection from such treatments against
SBV infection [170]. Strategic management of the
breeding season has also been suggested [95]; adjusting
the breeding season to avoid having animals at the
most critical phase of gestation during the period when
SBV arbovirus vectors are most active (vector-active
period spans from April to November in Ireland), may
help reduce the possibility of virus transmission. How-
ever, this could result in significant implications for
both sheep and cattle management in seasonal-based
production systems (such as in Ireland). Moreover,
changing breeding times for livestock is likely to have
economic implications for farmers, particularly for early
lambing sheep farms.
In addition to this, grazing/managing youngstock out-
side during the vector-active season may help facilitate
exposure to vectors, possibly resulting in natural SBV in-
fection. In this instance, young animals are more likely
to be exposed to SBV before their first breeding season.
Considering that naturally acquired SBV immunity is
thought to be long-lasting; anti-SBV antibodies are
detectable for at least 2-3 years following natural infec-
tion cattle and sheep [116–118] the immunity acquired
as a calf/lamb may help prevent SBV infection in breed-
ing/pregnant females later in life. However, bearing in
mind the inconsistent and intermittent circulation of
SBV in previously exposed regions following the Euro-
pean Schmallenberg epidemic in 2011/2012, this method
is unlikely be very reliable on its own. Rather, a combin-
ation of a number of control measures is required to re-
duce the risk of SBV infection in domestic livestock.
Conclusions
Since SBV was first identified in 2011, a considerable
body of scientific research has been conducted inter-
nationally on this novel emerging virus. This review pro-
vides a comprehensive synopsis of the most up-to-date
scientific literature regarding SBV internationally. More-
over, the review also highlights current knowledge gaps
in the literature, most notably the need for further re-
search to determine if, and to what extent, SBV circula-
tion occurred in Europe during 2017 and 2018. This
information will be critical to determine the current
herd immunity to SBV in Europe and can in turn be
used by policy makers, veterinarians and farmers to in-
form decisions regarding the future risk of SBV circula-
tion and epidemics. The authors of this review
recommend that SBV circulation in continental Euro-
pean countries during 2017 and 2018 be investigated.
The results of this review also highlight that currently,
there is no commercial vaccine available to protect do-
mestic ruminants against SBV infection, and historically
when a vaccine was available, uptake was low. It would
therefore be prudent to continue monitoring for
Schmallenberg virus circulation in previously exposed
and unexposed regions in Europe. Moreover, the estab-
lishment of a European-wide sentinel herd arbovirus
surveillance program, which incorporates bovine ser-
ology and Culicoides entomology and virology studies, at
national and international level to monitor for the emer-
gence and re-emergence of arboviruses such as SBV,
bluetongue virus or other novel Culicoides-borne arbovi-
ruses, is also recommended.
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